Literature DB >> 17229703

Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.

Ingrid Mannigel1, Annett Stange, Hanswalter Zentgraf, Dirk Lindemann.   

Abstract

Unlike other retrovirus Gag proteins, the prototype foamy virus (PFV) p71(g)(ag) protein is not processed into mature matrix (MA), capsid (CA), and nucleocapsid (NC) subunits. Little information about sequence motifs involved in FV capsid assembly and release is available. The recent analysis of candidate L-domain motifs in PFV Gag identified an evolutionarily conserved YXXL sequence motif with a potential function in capsid assembly. Here we provide support for the hypothesis that this motif does not function like a conventional L domain, by demonstrating that, unlike the PFV Gag PSAP L-domain motif, it cannot be functionally replaced by heterologous L-domain sequences. Furthermore, mutation of individual amino acids Y(464), I(466), L(467), and L(469), but not E(465), to alanine led to reduced particle release and production of noninfectious, aberrant capsid structures, although relative structural protein incorporation and processing were not affected. In contrast, mutation of G(468) to alanine resulted in an intermediate, temperature-sensitive phenotype characterized by reduced particle release and reduced infectivity. Despite similar relative RNA genome incorporation for all mutants, analysis and quantification of particle-associated viral nucleic acids demonstrated defects in genomic reverse transcription for all the noninfectious mutants, a process that, unlike that of orthoretroviruses, in the case of FVs takes place in the virus-producing cell. In correlation with the reduced infectivity, the G(468)A mutant displayed an intermediate level of genomic reverse transcription. Taken together, these results demonstrate that the conserved YXXLGL motif in PFV Gag is involved in correct capsid assembly, which in turn is essential for reverse transcription of the FV genome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229703      PMCID: PMC1866044          DOI: 10.1128/JVI.01866-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity.

Authors:  Annett Stange; Ingrid Mannigel; Katrin Peters; Martin Heinkelein; Nicole Stanke; Marc Cartellieri; Heinrich Göttlinger; Axel Rethwilm; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Identification of domains in gag important for prototypic foamy virus egress.

Authors:  Gillian S Patton; Stephen A Morris; Wayne Chung; Paul D Bieniasz; Myra O McClure
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.

Authors:  G Choi; S Park; B Choi; S Hong; J Lee; E Hunter; S S Rhee
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.

Authors:  K I Pfrepper; M Löchelt; H R Rackwitz; M Schnölzer; H Heid; R M Flügel
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.

Authors:  D Lindemann; T Pietschmann; M Picard-Maureau; A Berg; M Heinkelein; J Thurow; P Knaus; H Zentgraf; A Rethwilm
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Properties of human foamy virus relevant to its development as a vector for gene therapy.

Authors:  Claire L Hill; Paul D Bieniasz; Myra O McClure
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

9.  Evidence that the human foamy virus genome is DNA.

Authors:  S F Yu; M D Sullivan; M L Linial
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.

Authors:  J B Bowzard; R P Bennett; N K Krishna; S M Ernst; A Rein; J W Wills
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  20 in total

1.  Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.

Authors:  Erik Müllers; Tobias Uhlig; Kristin Stirnnagel; Uwe Fiebig; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  Basic residues in the foamy virus Gag protein.

Authors:  Daniel Matthes; Tatiana Wiktorowicz; Juliane Zahn; Jochen Bodem; Nicole Stanke; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry.

Authors:  Sylvia Hütter; Erik Müllers; Nicole Stanke; Juliane Reh; Dirk Lindemann
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

4.  A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.

Authors:  Yu-Ping Ho; Viktor Schnabel; Anka Swiersy; Kristin Stirnnagel; Dirk Lindemann
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

5.  Genetic characterization of simian foamy viruses infecting humans.

Authors:  Réjane Rua; Edouard Betsem; Sara Calattini; Ali Saib; Antoine Gessain
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

6.  Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.

Authors:  Martin V Hamann; Nicole Stanke; Erik Müllers; Kristin Stirnnagel; Sylvia Hütter; Benedetta Artegiani; Sara Bragado Alonso; Federico Calegari; Dirk Lindemann
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

7.  Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.

Authors:  Kristin Stirnnagel; Daniel Lüftenegger; Annett Stange; Anka Swiersy; Erik Müllers; Juliane Reh; Nicole Stanke; Arend Grosse; Salvatore Chiantia; Heiko Keller; Petra Schwille; Helmut Hanenberg; Hanswalter Zentgraf; Dirk Lindemann
Journal:  Retrovirology       Date:  2010-05-17       Impact factor: 4.602

8.  The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding.

Authors:  Vincent Dussupt; Melodi P Javid; Georges Abou-Jaoudé; Joshua A Jadwin; Jason de La Cruz; Kunio Nagashima; Fadila Bouamr
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

9.  An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity.

Authors:  Juliane Reh; Annett Stange; Anne Götz; Marlene Rönitz; Arend Große; Dirk Lindemann
Journal:  Retrovirology       Date:  2013-04-25       Impact factor: 4.602

10.  A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid.

Authors:  David C Goldstone; Thomas G Flower; Neil J Ball; Marta Sanz-Ramos; Melvyn W Yap; Roksana W Ogrodowicz; Nicole Stanke; Juliane Reh; Dirk Lindemann; Jonathan P Stoye; Ian A Taylor
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.